About Kinderklink Siegen Deutsches Rotes Kreuz
"Fachklinik für Kinder und Jugendliche seit über 100 Jahren Gegründet 1918 sind wir seit über 100 Jahren der verlässliche Partner für die Gesundheitsversorgung der Kinder und Jugendlichen der Region Siegen-Wittgenstein und weit darüber hinaus. Über 900 Mitarbeiterinnen & Mitarbeiter sorgen 365 Tage im Jahr rund um die Uhr für eine medizinische, therapeutische und pflegerische Versorgung auf höchstem Niveau."
Clinical Trials at Kinderklink Siegen Deutsches Rotes Kreuz
During the past decade, Kinderklink Siegen Deutsches Rotes Kreuz conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kinderklink Siegen Deutsches Rotes Kreuz" #1 sponsor was "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials, followed by "European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma" with 1 trials
sponsored, "University Hospital Schleswig-Holstein" with 1 trials sponsored, "University Hospital Tuebingen" with 1 trials sponsored and "University of Cologne"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kinderklink Siegen Deutsches Rotes Kreuz"
#1 collaborator was "Altona Children's Hospital" with 1 trials as a collaborator, "Asklepios Kliniken Hamburg GmbH" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "DRK Kinderklinik Siegen" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Kinderklink Siegen Deutsches Rotes Kreuz
According to Clinical.Site data, the most researched conditions in "Kinderklink Siegen Deutsches Rotes Kreuz" are
"Neuroblastoma" (2 trials), "Anemia of Prematurity" (1 trials), "Brain and Central Nervous System Tumors" (1 trials), "Leukemia" (1 trials) and "Long-term Effects Secondary to Cancer Therapy in Children" (1 trials). Many other conditions were trialed in "Kinderklink Siegen Deutsches Rotes Kreuz" in a lesser frequency.
Clinical Trials Intervention Types at Kinderklink Siegen Deutsches Rotes Kreuz
Most popular intervention types in "Kinderklink Siegen Deutsches Rotes Kreuz" are "Drug" (5 trials), "Radiation" (5 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "ifosfamide" (4 trials), "radiation therapy" (4 trials), "vindesine" (4 trials), "autologous hematopoietic stem cell transplantation" (3 trials) and "carboplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Kinderklink Siegen Deutsches Rotes Kreuz
The vast majority of trials in "Kinderklink Siegen Deutsches Rotes Kreuz" are
7 trials for "All" genders.
Clinical Trials Status at Kinderklink Siegen Deutsches Rotes Kreuz
Currently, there are NaN active trials in "Kinderklink Siegen Deutsches Rotes Kreuz".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Kinderklink Siegen Deutsches Rotes Kreuz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kinderklink Siegen Deutsches Rotes Kreuz, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".